27% growth in prescriptions dispensed over prior quarter; 147% growth over comparable quarter in 2022. 5 consecutive quarters of double-digit growth. Click here to learn more ›

Bremelanotide for Hypoactive Sexual Desire Disorder: Analyses From a Phase 2B Dose‐Ranging Study

Leave a Reply

Scroll to Top